Akeso Biomedical
Dr. Sinskey is a Professor of Microbiology and Engineering Systems at The Massachusetts Institute of Technology, or MIT, and Professor of Health Science and Technology at the Harvard-MIT Division of Health Sciences and Technology. He has been a member of the MIT faculty since 1968. Dr. Sinskey also holds positions as Co-Director of the Malaysia-MIT Biotechnology Partnership Program and as Faculty Director of the Center for Biomedical Innovation. Dr. Sinskey is a co-founder and a member of the boards of directors of Metabolix, Inc. (NASDAQ: MBLX) and Tepha, Inc., and a consultant to several chemical and biotechnology companies.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Akeso Biomedical
Akeso Biomedical is an early stage company focused on developing new solutions for the treatment of bacterial infections, microbial biofilms, and chronic wounds. The Company is developing products to treat these conditions using a new class of compounds, known as Fe3C, that have broad-spectrum activity against a wide range of bacteria, and a silk biomaterial technology exclusively licensed from Tufts University.